JAMA (Journal of the American Medical Association)

FDA Approves Novel Treatment for Chronic Hepatitis B
https://jamanetwork.com/journals/jama/fullarticle/2856883

The US Food and Drug Administration (FDA) approved bepirovirsen, marketed as Hibsago, in combination with existing antiviral therapy for adults without cirrhosis who have chronic hepatitis B virus (HBV) infection.

Updated Guidance Released for Type 2 Diabetes Care
https://jamanetwork.com/journals/jama/fullarticle/2856884

The American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) released a joint consensus statement offering updated clinical guidance for type 2 diabetes.

Personalized mRNA Cancer Vaccine Reduces Melanoma Recurrence Risk
https://jamanetwork.com/journals/jama/fullarticle/2856885

A personalized messenger RNA (mRNA) cancer vaccine significantly lowered the risk of disease recurrence or death in patients with high-risk melanoma, a phase 3 trial found.